BioSpace News Archive

Monarch Medical Technologies, the leader in precision insulin dosing for optimized inpatient glucose management, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of an additional feature of Monarch EndoTool SubQ, an insulin-on-board (IOB) algorithm.

Laxogenin 100™ body building supplement is the product every athlete or health conscious person has been waiting for!

Moderna, Inc., (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced that Stephane Bancel, Chief Executive Officer, and Lorence Kim, M.D., Chief Financial Officer, will present at the Goldman Sachs 40th Annual Global Healthcare Conference

Technavio’s latest market research report on the global uveitis drugs market predicts the market to witness a CAGR of close to 7% during the forecast period.

La Fondation Dassault Systèmes, a foundation dedicated to transforming the future of education and research with the learning and discovery capabilities of 3D technology and virtual universes, today announced the development of the Ocean Explorers project to support the preservation of the world’s oceans, which play a major role in climate change.

Recognizing the importance of ensuring people with disabilities have access to the care and services they need to live better, healthier lives, WellCare Health Plans, Inc. and its Staywell Health Plan have donated $15,000 to sponsor the 21st Annual Family Café in Orlando, Florida June 7-9.

Actress Elsa Pataky has joined the Swisse family as a Global Brand Ambassador.

ProtoKinetix, Incorporated (www.protokinetix.com) (the “Company” or “ProtoKinetix”) (OTCQB:PKTX) today announced reaching the midpoint of a Phase-1 first-in-human clinical trial of AAGP® PKX-001 treated islet cells used in conjunction with the Edmonton Protocol for the treatment of Type-1 diabetes

The Supreme Cannabis Company, Inc. (“Supreme Cannabis” or the “Company”) (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1), today announced it has entered into an agreement with Pax Labs, Inc. (“PAX”), to become a foundational brand partner and supplier for the PAX Era in Canada, pending the federal legalization of the vaporizable products.

Aphria Inc. (“Aphria” or the “Company”) (TSX: APHA and NYSE: APHA) today announced an agreement with San Francisco-based PAX Labs, Inc. (“PAX”), a leader in the design and development of premium cannabis vaporization devices, that will enable Aphria to provide premium cannabis extracts in pods designed for use with PAX’s innovative Era device and platform.